SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5c24'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_D_DVAD8_0 (GRAMICIDIN A)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	3 / 3	TRP B 266 VAL B 261 TRP B 426	None	1.29A	1c4dC-5c24B: undetectable 1c4dD-5c24B: undetectable	1c4dC-5c24B: 3.19 1c4dD-5c24B: 3.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7A_A_PFLA4002_1 (SERUM ALBUMIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	3 / 3	PHE B 116 LEU B 120 SER B 156	None	0.88A	1e7aA-5c24B: undetectable	1e7aA-5c24B: 21.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FK9_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 188 GLY B 190	None	0.84A	1fk9A-5c24B: 11.5	1fk9A-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FK9_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.72A	1fk9A-5c24B: 11.5	1fk9A-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 11	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.34A	1fkpA-5c24B: 6.9	1fkpA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IKW_A_EFZA2000_1 (POL POLYPROTEIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 188 GLY B 190	None	0.84A	1ikwA-5c24B: 14.9	1ikwA-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IKW_A_EFZA2000_1 (POL POLYPROTEIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.70A	1ikwA-5c24B: 14.9	1ikwA-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1JKH_A_EFZA999_1 (HIV-1 RT, A-CHAIN HIV-1 RT, B-CHAIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 11	LYS B 103 VAL B 106 VAL B 179 TYR B 188 GLY B 190	None	0.87A	1jkhA-5c24B: 12.8 1jkhB-5c24B: 51.2	1jkhA-5c24B: 96.46 1jkhB-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LW0_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.61A	1lw0A-5c24B: 11.1	1lw0A-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWC_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 11	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.68A	1lwcA-5c24B: 10.4	1lwcA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWE_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 7	VAL B 106 TYR B 181 TYR B 188 GLY B 190	None	0.47A	1lweA-5c24B: 18.9	1lweA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWF_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 9	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.47A	1lwfA-5c24B: 5.4	1lwfA-5c24B: 95.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S1U_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.59A	1s1uA-5c24B: 14.2	1s1uA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S1X_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 8	VAL B 106 TYR B 181 TYR B 188 GLY B 190	None	0.39A	1s1xA-5c24B: 12.4	1s1xA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 7	ASP B 110 MET B 184 ASP B 185 ASP B 186	None	1.43A	1t03A-5c24B: 10.9	1t03A-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 7	ASP B 110 MET B 184 ASP B 186 LYS B 227	None	1.39A	1t03A-5c24B: 10.9	1t03A-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 7	TYR B 183 MET B 184 ASP B 185 ASP B 186	None	1.09A	1t03A-5c24B: 10.9	1t03A-5c24B: 96.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_J_CHDJ3060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 6	LEU B 109 MET B 164 THR B 165 LEU B 168	None	0.79A	1v54A-5c24B: 2.2 1v54J-5c24B: undetectable	1v54A-5c24B: 20.11 1v54J-5c24B: 10.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1VRT_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 9	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.27A	1vrtA-5c24B: 10.9	1vrtA-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YA3_B_STRB2001_1 (MINERALOCORTICOID RECEPTOR)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LEU B 80 GLN B 151 MET B 184 ARG B 72 THR B 84	None	1.45A	1ya3B-5c24B: undetectable	1ya3B-5c24B: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 6	LEU B 109 MET B 164 THR B 165 LEU B 168	None	0.78A	2dyrA-5c24B: 2.3 2dyrJ-5c24B: undetectable	2dyrA-5c24B: 20.11 2dyrJ-5c24B: 10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 6	LEU B 109 MET B 164 THR B 165 LEU B 168	None	0.77A	2eijA-5c24B: 2.4 2eijJ-5c24B: undetectable	2eijA-5c24B: 20.11 2eijJ-5c24B: 10.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HND_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.69A	2hndA-5c24B: 18.4	2hndA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HNY_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.70A	2hnyA-5c24B: 10.9	2hnyA-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ZD1_A_T27A557_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.77A	2zd1A-5c24B: 11.7	2zd1A-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 6	LEU B 109 MET B 164 THR B 165 LEU B 168	None	0.79A	3abmA-5c24B: 2.4 3abmJ-5c24B: undetectable	3abmA-5c24B: 20.11 3abmJ-5c24B: 10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_F_SVRF509_2 (PHOSPHOLIPASE A2)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 8	LYS B 166 PRO B 150 PHE B 77 TRP B 153	None	1.32A	3bjwD-5c24B: undetectable	3bjwD-5c24B: 14.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HVT_A_NVPA557_1 (HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66))	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 9	LYS B 103 VAL B 106 TYR B 181 TYR B 188 GLY B 190	None	1.03A	3hvtA-5c24B: 9.2	3hvtA-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LP0_A_NVPA701_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 9	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.61A	3lp0A-5c24B: 8.0	3lp0A-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LP1_A_NVPA701_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.54A	3lp1A-5c24B: 11.8	3lp1A-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 GLY B 190	None	1.15A	3mecA-5c24B: 12.0	3mecA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.90A	3mecA-5c24B: 12.0	3mecA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.74A	3medA-5c24B: 8.8 3medB-5c24B: 17.7	3medA-5c24B: 96.46 3medB-5c24B: 96.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MEE_A_T27A561_1 (P66 REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.98A	3meeA-5c24B: 14.1	3meeA-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3O7W_A_SAMA801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 1)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	3 / 3	LYS B 374 ARG B 356 ASP B 237	None	1.39A	3o7wA-5c24B: undetectable	3o7wA-5c24B: 21.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QIP_A_NVPA561_1 (REVERSE HIV-1 REVERSE TRANSCRIPTASE P66)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	6 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.67A	3qipA-5c24B: 11.8	3qipA-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_H_ACTH504_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	3 / 3	LYS B 388 GLU B 413 TRP B 414	None	1.28A	3v4tH-5c24B: undetectable	3v4tH-5c24B: 22.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4B3O_A_EFZA1557_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 9	LYS B 103 VAL B 106 TYR B 181 TYR B 188 GLY B 190	None	0.79A	4b3oA-5c24B: 10.7	4b3oA-5c24B: 95.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F8Y_C_VK3C202_1 (NADPH QUINONE OXIDOREDUCTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 7	ARG B 358 TYR B 232 LEU B 234 TYR B 339	None	1.29A	4f8yC-5c24B: undetectable 4f8yD-5c24B: undetectable	4f8yC-5c24B: 17.96 4f8yD-5c24B: 17.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1Q_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.71A	4g1qA-5c24B: 11.9	4g1qA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ICL_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.71A	4iclA-5c24B: 10.8	4iclA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ID5_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.73A	4id5A-5c24B: 9.5	4id5A-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IDK_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.69A	4idkA-5c24B: 11.8	4idkA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IFV_A_T27A601_1 (EXORIBONUCLEASE H, P66 RT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.72A	4ifvA-5c24B: 10.7	4ifvA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IFY_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.69A	4ifyA-5c24B: 10.9	4ifyA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IG3_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.76A	4ig3A-5c24B: 19.4	4ig3A-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KFB_A_T27A607_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H, EXORIBONUCLEA P66 RT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.64A	4kfbA-5c24B: 10.7	4kfbA-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L4E_A_CAMA503_0 (CAMPHOR 5-MONOOXYGENASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 8	THR B 377 LEU B 234 VAL B 106 ASP B 186	None	1.12A	4l4eA-5c24B: undetectable	4l4eA-5c24B: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L4F_A_CAMA503_0 (CAMPHOR 5-MONOOXYGENASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 8	THR B 377 LEU B 234 VAL B 106 ASP B 186	None	1.09A	4l4fA-5c24B: undetectable	4l4fA-5c24B: 20.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PWD_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 8	VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.41A	4pwdC-5c24B: 10.4	4pwdC-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q0B_A_NVPA901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 8	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.78A	4q0bA-5c24B: 10.9	4q0bA-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q0B_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 9	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.67A	4q0bC-5c24B: 9.9	4q0bC-5c24B: 96.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CYM_A_T27A601_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.73A	5cymA-5c24B: 11.7	5cymA-5c24B: 96.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CYQ_A_T27A601_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.75A	5cyqA-5c24B: 10.8	5cyqA-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GQB_A_GCSA602_1 (CHITINASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	3 / 3	TRP B 414 GLU B 413 ASP B 76	None	0.97A	5gqbA-5c24B: undetectable	5gqbA-5c24B: 20.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HBM_A_NVPA601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 11	VAL B 106 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.30A	5hbmA-5c24B: 11.9	5hbmA-5c24B: 96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	4 / 6	LEU B 109 MET B 164 THR B 165 LEU B 168	None	0.76A	5x1fA-5c24B: 2.5 5x1fJ-5c24B: undetectable	5x1fA-5c24B: 20.11 5x1fJ-5c24B: 10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B0L_B_TA1B502_1 (TUBULIN BETA CHAIN)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LEU B 205 LEU B 168 PRO B 97 GLY B 99 LEU B 100	None	1.01A	6b0lB-5c24B: undetectable	6b0lB-5c24B: 12.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSG_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 188 GLY B 190	None	1.06A	6bsgA-5c24B: 11.0	6bsgA-5c24B: 98.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSG_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.84A	6bsgA-5c24B: 11.0	6bsgA-5c24B: 98.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSI_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 106 VAL B 179 TYR B 188 GLY B 190	None	1.07A	6bsiA-5c24B: 11.2	6bsiA-5c24B: 98.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSI_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 10	LYS B 103 VAL B 179 TYR B 181 TYR B 188 GLY B 190	None	0.82A	6bsiA-5c24B: 11.2	6bsiA-5c24B: 98.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6ELI_A_T27A701_1 (REVERSE TRANSCRIPTASE)	5c24	HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT (Human immunodeficiency virus 1)	5 / 12	LYS B 103 VAL B 106 VAL B 179 TYR B 181 TYR B 188	None	0.73A	6eliA-5c24B: 11.9	6eliA-5c24B: 100.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C4D_D_DVAD8_0","GRAMICIDIN A","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",3,"TRP B 266;VAL B 261;TRP B 426","None","1.29A","1c4dC-5c24B:undetectable;1c4dD-5c24B:undetectable","1c4dC-5c24B:3.19;1c4dD-5c24B:3.19"],["1E7A_A_PFLA4002_1","SERUM ALBUMIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",3,"PHE B 116;LEU B 120;SER B 156","None","0.88A","1e7aA-5c24B:undetectable","1e7aA-5c24B:21.59"],["1FK9_A_EFZA999_1","HIV-1 RT, A-CHAIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 188;GLY B 190","None","0.84A","1fk9A-5c24B:11.5","1fk9A-5c24B:96.70"],["1FK9_A_EFZA999_1","HIV-1 RT, A-CHAIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.72A","1fk9A-5c24B:11.5","1fk9A-5c24B:96.70"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.34A","1fkpA-5c24B:6.9","1fkpA-5c24B:96.46"],["1IKW_A_EFZA2000_1","POL POLYPROTEIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 188;GLY B 190","None","0.84A","1ikwA-5c24B:14.9","1ikwA-5c24B:96.93"],["1IKW_A_EFZA2000_1","POL POLYPROTEIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.70A","1ikwA-5c24B:14.9","1ikwA-5c24B:96.93"],["1JKH_A_EFZA999_1","HIV-1 RT, A-CHAIN;HIV-1 RT, B-CHAIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 188;GLY B 190","None","0.87A","1jkhA-5c24B:12.8;1jkhB-5c24B:51.2","1jkhA-5c24B:96.46;1jkhB-5c24B:96.46"],["1LW0_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.61A","1lw0A-5c24B:11.1","1lw0A-5c24B:96.70"],["1LWC_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.68A","1lwcA-5c24B:10.4","1lwcA-5c24B:96.46"],["1LWE_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"VAL B 106;TYR B 181;TYR B 188;GLY B 190","None","0.47A","1lweA-5c24B:18.9","1lweA-5c24B:96.46"],["1LWF_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.47A","1lwfA-5c24B:5.4","1lwfA-5c24B:95.75"],["1S1U_A_NVPA999_1","REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.59A","1s1uA-5c24B:14.2","1s1uA-5c24B:96.46"],["1S1X_A_NVPA999_1","REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"VAL B 106;TYR B 181;TYR B 188;GLY B 190","None","0.39A","1s1xA-5c24B:12.4","1s1xA-5c24B:96.46"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"ASP B 110;MET B 184;ASP B 185;ASP B 186","None","1.43A","1t03A-5c24B:10.9","1t03A-5c24B:96.93"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"ASP B 110;MET B 184;ASP B 186;LYS B 227","None","1.39A","1t03A-5c24B:10.9","1t03A-5c24B:96.93"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"TYR B 183;MET B 184;ASP B 185;ASP B 186","None","1.09A","1t03A-5c24B:10.9","1t03A-5c24B:96.93"],["1V54_J_CHDJ3060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"LEU B 109;MET B 164;THR B 165;LEU B 168","None","0.79A","1v54A-5c24B:2.2;1v54J-5c24B:undetectable","1v54A-5c24B:20.11;1v54J-5c24B:10.79"],["1VRT_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.27A","1vrtA-5c24B:10.9","1vrtA-5c24B:96.70"],["1YA3_B_STRB2001_1","MINERALOCORTICOID RECEPTOR","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LEU B  80;GLN B 151;MET B 184;ARG B  72;THR B  84","None","1.45A","1ya3B-5c24B:undetectable","1ya3B-5c24B:21.74"],["2DYR_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"LEU B 109;MET B 164;THR B 165;LEU B 168","None","0.78A","2dyrA-5c24B:2.3;2dyrJ-5c24B:undetectable","2dyrA-5c24B:20.11;2dyrJ-5c24B:10.79"],["2EIJ_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"LEU B 109;MET B 164;THR B 165;LEU B 168","None","0.77A","2eijA-5c24B:2.4;2eijJ-5c24B:undetectable","2eijA-5c24B:20.11;2eijJ-5c24B:10.79"],["2HND_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.69A","2hndA-5c24B:18.4","2hndA-5c24B:96.46"],["2HNY_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.70A","2hnyA-5c24B:10.9","2hnyA-5c24B:96.46"],["2ZD1_A_T27A557_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.77A","2zd1A-5c24B:11.7","2zd1A-5c24B:96.70"],["3ABM_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"LEU B 109;MET B 164;THR B 165;LEU B 168","None","0.79A","3abmA-5c24B:2.4;3abmJ-5c24B:undetectable","3abmA-5c24B:20.11;3abmJ-5c24B:10.79"],["3BJW_F_SVRF509_2","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"LYS B 166;PRO B 150;PHE B  77;TRP B 153","None","1.32A","3bjwD-5c24B:undetectable","3bjwD-5c24B:14.21"],["3HVT_A_NVPA557_1","HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66)","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;TYR B 181;TYR B 188;GLY B 190","None","1.03A","3hvtA-5c24B:9.2","3hvtA-5c24B:96.93"],["3LP0_A_NVPA701_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.61A","3lp0A-5c24B:8.0","3lp0A-5c24B:96.46"],["3LP1_A_NVPA701_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.54A","3lp1A-5c24B:11.8","3lp1A-5c24B:96.46"],["3MEC_A_65BA561_0","P66 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;GLY B 190","None","1.15A","3mecA-5c24B:12.0","3mecA-5c24B:96.70"],["3MEC_A_65BA561_0","P66 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.90A","3mecA-5c24B:12.0","3mecA-5c24B:96.70"],["3MED_A_65BA561_0","P51 REVERSE TRANSCRIPTASE;P66 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.74A","3medA-5c24B:8.8;3medB-5c24B:17.7","3medA-5c24B:96.46;3medB-5c24B:96.46"],["3MEE_A_T27A561_1","P66 REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.98A","3meeA-5c24B:14.1","3meeA-5c24B:96.70"],["3O7W_A_SAMA801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 1","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",3,"LYS B 374;ARG B 356;ASP B 237","None","1.39A","3o7wA-5c24B:undetectable","3o7wA-5c24B:21.50"],["3QIP_A_NVPA561_1","REVERSE HIV-1 REVERSE TRANSCRIPTASE P66","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",6,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.67A","3qipA-5c24B:11.8","3qipA-5c24B:96.70"],["3V4T_H_ACTH504_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",3,"LYS B 388;GLU B 413;TRP B 414","None","1.28A","3v4tH-5c24B:undetectable","3v4tH-5c24B:22.76"],["4B3O_A_EFZA1557_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;TYR B 181;TYR B 188;GLY B 190","None","0.79A","4b3oA-5c24B:10.7","4b3oA-5c24B:95.99"],["4F8Y_C_VK3C202_1","NADPH QUINONE OXIDOREDUCTASE;NADPH QUINONE OXIDOREDUCTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"ARG B 358;TYR B 232;LEU B 234;TYR B 339","None","1.29A","4f8yC-5c24B:undetectable;4f8yD-5c24B:undetectable","4f8yC-5c24B:17.96;4f8yD-5c24B:17.96"],["4G1Q_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.71A","4g1qA-5c24B:11.9","4g1qA-5c24B:96.70"],["4ICL_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.71A","4iclA-5c24B:10.8","4iclA-5c24B:96.70"],["4ID5_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.73A","4id5A-5c24B:9.5","4id5A-5c24B:96.70"],["4IDK_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.69A","4idkA-5c24B:11.8","4idkA-5c24B:96.70"],["4IFV_A_T27A601_1","EXORIBONUCLEASE H, P66 RT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.72A","4ifvA-5c24B:10.7","4ifvA-5c24B:96.70"],["4IFY_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.69A","4ifyA-5c24B:10.9","4ifyA-5c24B:96.70"],["4IG3_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.76A","4ig3A-5c24B:19.4","4ig3A-5c24B:96.70"],["4KFB_A_T27A607_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H, EXORIBONUCLEA P66 RT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.64A","4kfbA-5c24B:10.7","4kfbA-5c24B:96.70"],["4L4E_A_CAMA503_0","CAMPHOR 5-MONOOXYGENASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"THR B 377;LEU B 234;VAL B 106;ASP B 186","None","1.12A","4l4eA-5c24B:undetectable","4l4eA-5c24B:18.88"],["4L4F_A_CAMA503_0","CAMPHOR 5-MONOOXYGENASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"THR B 377;LEU B 234;VAL B 106;ASP B 186","None","1.09A","4l4fA-5c24B:undetectable","4l4fA-5c24B:20.63"],["4PWD_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.41A","4pwdC-5c24B:10.4","4pwdC-5c24B:96.93"],["4Q0B_A_NVPA901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.78A","4q0bA-5c24B:10.9","4q0bA-5c24B:96.93"],["4Q0B_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.67A","4q0bC-5c24B:9.9","4q0bC-5c24B:96.93"],["5CYM_A_T27A601_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.73A","5cymA-5c24B:11.7","5cymA-5c24B:96.70"],["5CYQ_A_T27A601_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.75A","5cyqA-5c24B:10.8","5cyqA-5c24B:96.70"],["5GQB_A_GCSA602_1","CHITINASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",3,"TRP B 414;GLU B 413;ASP B  76","None","0.97A","5gqbA-5c24B:undetectable","5gqbA-5c24B:20.28"],["5HBM_A_NVPA601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"VAL B 106;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.30A","5hbmA-5c24B:11.9","5hbmA-5c24B:96.70"],["5X1F_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",4,"LEU B 109;MET B 164;THR B 165;LEU B 168","None","0.76A","5x1fA-5c24B:2.5;5x1fJ-5c24B:undetectable","5x1fA-5c24B:20.11;5x1fJ-5c24B:10.79"],["6B0L_B_TA1B502_1","TUBULIN BETA CHAIN","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LEU B 205;LEU B 168;PRO B  97;GLY B  99;LEU B 100","None","1.01A","6b0lB-5c24B:undetectable","6b0lB-5c24B:12.94"],["6BSG_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 188;GLY B 190","None","1.06A","6bsgA-5c24B:11.0","6bsgA-5c24B:98.67"],["6BSG_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.84A","6bsgA-5c24B:11.0","6bsgA-5c24B:98.67"],["6BSI_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 188;GLY B 190","None","1.07A","6bsiA-5c24B:11.2","6bsiA-5c24B:98.67"],["6BSI_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 179;TYR B 181;TYR B 188;GLY B 190","None","0.82A","6bsiA-5c24B:11.2","6bsiA-5c24B:98.67"],["6ELI_A_T27A701_1","REVERSE TRANSCRIPTASE","5c24","HIV-1 REVERSE TRANSCRIPTASE, P51 SUBUNIT","Human immunodeficiency virus 1",5,"LYS B 103;VAL B 106;VAL B 179;TYR B 181;TYR B 188","None","0.73A","6eliA-5c24B:11.9","6eliA-5c24B:100.00"]]